🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/03/1987 | 8,38 | 8,40 | 8,28 | 8,30 | -1,10% | 1,42% | 8.571.802 |
| 11/03/1987 | 8,53 | 8,56 | 8,40 | 8,40 | -1,09% | 1,94% | 9.671.573 |
| 10/03/1987 | 8,45 | 8,53 | 8,39 | 8,49 | +0,71% | 1,73% | 7.911.562 |
| 09/03/1987 | 8,51 | 8,51 | 8,34 | 8,43 | -1,70% | 2,10% | 6.636.355 |
| 06/03/1987 | 8,53 | 8,57 | 8,46 | 8,57 | +0,70% | 1,40% | 8.000.222 |
| 05/03/1987 | 8,53 | 8,59 | 8,47 | 8,51 | +1,34% | 1,40% | 10.537.430 |
| 04/03/1987 | 8,32 | 8,46 | 8,24 | 8,40 | +1,12% | 2,63% | 15.206.270 |
| 03/03/1987 | 8,24 | 8,38 | 8,24 | 8,31 | +0,97% | 1,61% | 9.265.997 |
| 02/03/1987 | 8,16 | 8,27 | 8,14 | 8,23 | +0,65% | 1,62% | 7.792.718 |
| 27/02/1987 | 8,12 | 8,19 | 8,06 | 8,18 | +0,65% | 1,63% | 6.679.742 |
| 26/02/1987 | 8,22 | 8,24 | 8,12 | 8,12 | -1,21% | 1,45% | 7.460.712 |
| 25/02/1987 | 8,12 | 8,30 | 8,12 | 8,22 | +1,80% | 2,12% | 9.967.738 |
| 24/02/1987 | 7,90 | 8,14 | 7,90 | 8,08 | +2,78% | 3,02% | 9.207.518 |
| 23/02/1987 | 7,91 | 7,94 | 7,74 | 7,86 | -0,84% | 2,51% | 10.888.301 |
| 20/02/1987 | 7,98 | 8,00 | 7,90 | 7,93 | +1,18% | 1,33% | 22.070.880 |
| 19/02/1987 | 7,52 | 7,85 | 7,47 | 7,83 | +4,51% | 4,93% | 15.072.336 |
| 18/02/1987 | 7,82 | 7,85 | 7,42 | 7,49 | -1,82% | 5,42% | 16.047.605 |
| 17/02/1987 | 7,40 | 7,67 | 7,40 | 7,63 | +3,23% | 3,76% | 8.915.126 |
| 13/02/1987 | 7,25 | 7,45 | 7,25 | 7,40 | +2,48% | 2,74% | 8.624.621 |
| 12/02/1987 | 7,12 | 7,26 | 7,11 | 7,22 | +1,87% | 2,14% | 11.899.411 |
| 11/02/1987 | 7,16 | 7,16 | 7,05 | 7,08 | -0,74% | 1,48% | 10.601.568 |
| 10/02/1987 | 7,23 | 7,25 | 7,10 | 7,14 | -1,19% | 2,02% | 7.796.491 |
| 09/02/1987 | 7,20 | 7,26 | 7,16 | 7,22 | -0,27% | 1,47% | 6.259.075 |
| 06/02/1987 | 7,25 | 7,29 | 7,20 | 7,24 | -0,27% | 1,28% | 5.581.858 |
| 05/02/1987 | 7,32 | 7,34 | 7,18 | 7,26 | -0,55% | 2,17% | 8.349.206 |
| 04/02/1987 | 7,36 | 7,36 | 7,26 | 7,30 | -0,36% | 1,26% | 7.223.026 |
| 03/02/1987 | 7,38 | 7,40 | 7,26 | 7,33 | -0,54% | 1,89% | 7.792.718 |
| 02/02/1987 | 7,28 | 7,46 | 7,24 | 7,37 | +1,09% | 3,10% | 7.107.955 |
| 30/01/1987 | 7,22 | 7,30 | 7,17 | 7,29 | +0,92% | 1,84% | 6.366.600 |
| 29/01/1987 | 7,45 | 7,46 | 7,18 | 7,22 | -2,50% | 3,74% | 8.283.182 |